Reported 1 day ago
In March, pharmaceutical imports to the U.S. soared as drug manufacturers prepared for potential tariffs being considered by the Trump administration, with total imports exceeding $50 billion, marking 20% of 2024's pharmaceutical imports. Ireland emerged as the leading exporter to the U.S., with imports significantly increasing in response to the looming trade policy changes. Companies like Pfizer and Merck have increased their inventories to safeguard against possible tariff impacts, as discussions about levying tariffs continue.
Source: YAHOO